273 related articles for article (PubMed ID: 8097493)
1. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.
Fidel PL; Lynch ME; Sobel JD
Infect Immun; 1993 May; 61(5):1990-5. PubMed ID: 8097493
[TBL] [Abstract][Full Text] [Related]
2. Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis.
Fidel PL; Lynch ME; Sobel JD
Infect Immun; 1994 Mar; 62(3):1032-8. PubMed ID: 8112837
[TBL] [Abstract][Full Text] [Related]
3. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis.
Fidel PL; Lynch ME; Sobel JD
Infect Immun; 1993 Oct; 61(10):4202-7. PubMed ID: 8406809
[TBL] [Abstract][Full Text] [Related]
4. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity.
Fidel PL; Lynch ME; Conaway DH; Tait L; Sobel JD
Infect Immun; 1995 Feb; 63(2):547-53. PubMed ID: 7822020
[TBL] [Abstract][Full Text] [Related]
5. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis.
Fidel PL; Lynch ME; Sobel JD
Infect Immun; 1995 Jul; 63(7):2403-8. PubMed ID: 7790050
[TBL] [Abstract][Full Text] [Related]
6. Persistent colonization and transient suppression of DTH responses in an estrogen-dependent vaginal candidosis murine model.
Hamad M; Abu-Elteen KH; Ghaleb M
New Microbiol; 2002 Jan; 25(1):65-73. PubMed ID: 11837393
[TBL] [Abstract][Full Text] [Related]
7. Candida-specific antibodies during experimental vaginal candidiasis in mice.
Wozniak KL; Wormley FL; Fidel PL
Infect Immun; 2002 Oct; 70(10):5790-9. PubMed ID: 12228309
[TBL] [Abstract][Full Text] [Related]
8. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen.
Fidel PL; Ginsburg KA; Cutright JL; Wolf NA; Leaman D; Dunlap K; Sobel JD
J Infect Dis; 1997 Sep; 176(3):728-39. PubMed ID: 9291322
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Candida albicans delayed-type hypersensitivity (DTH) model in the female B₆C₃F₁ mouse for use in immunotoxicological investigations.
White KL; McLoughlin CE; Auttachoat W; Smith MJ
J Immunotoxicol; 2012; 9(2):141-7. PubMed ID: 22339419
[TBL] [Abstract][Full Text] [Related]
10. Validation of a Candida albicans delayed-type hypersensitivity (DTH) model in female juvenile rats for use in immunotoxicity assessments.
Collinge M; Thorn M; Peachee V; White K
J Immunotoxicol; 2013; 10(4):341-8. PubMed ID: 23282408
[TBL] [Abstract][Full Text] [Related]
11. Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections.
Fidel PL; Cutright JL; Sobel JD
Infect Immun; 1995 Oct; 63(10):4191-4. PubMed ID: 7558342
[TBL] [Abstract][Full Text] [Related]
12. Multiple experimental designs to evaluate the role of T-cell-mediated immunity against experimental vaginal Candida albicans infection.
Wormley FL; Cutright J; Fidel PL
Med Mycol; 2003 Oct; 41(5):401-9. PubMed ID: 14653516
[TBL] [Abstract][Full Text] [Related]
13. CD4(+)-T-Cell-mediated resistance to systemic murine candidiasis induced by a membrane fraction of Candida albicans.
Mizutani S; Endo M; Ino-Ue T; Kurasawa M; Uno Y; Saito H; Onogi K; Kato I; Takesako K
Antimicrob Agents Chemother; 2000 Oct; 44(10):2653-8. PubMed ID: 10991839
[TBL] [Abstract][Full Text] [Related]
14. Immunity to Candida.
Fidel PL
Oral Dis; 2002; 8 Suppl 2():69-75. PubMed ID: 12164664
[TBL] [Abstract][Full Text] [Related]
15. Partial protection against experimental vaginal candidiasis after mucosal vaccination with heat-killed Candida albicans and the mucosal adjuvant LT(R192G).
Cárdenas-Freytag L; Steele C; Wormley FL; Cheng E; Clements JD; Fidel PL
Med Mycol; 2002 Jun; 40(3):291-9. PubMed ID: 12146759
[TBL] [Abstract][Full Text] [Related]
16. Studies of experimental candidiasis in T-cell-deficient mice.
Sinha BK; Prasad S; Monga DP
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jun; 265(1-2):203-9. PubMed ID: 3314257
[TBL] [Abstract][Full Text] [Related]
17. Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.
Domer JE; Garner RE; Befidi-Mengue RN
Infect Immun; 1989 Mar; 57(3):693-700. PubMed ID: 2917780
[TBL] [Abstract][Full Text] [Related]
18. A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice.
Mencacci A; Torosantucci A; Spaccapelo R; Romani L; Bistoni F; Cassone A
Infect Immun; 1994 Dec; 62(12):5353-60. PubMed ID: 7960114
[TBL] [Abstract][Full Text] [Related]
19. Vaginal Heparan Sulfate Linked to Neutrophil Dysfunction in the Acute Inflammatory Response Associated with Experimental Vulvovaginal Candidiasis.
Yano J; Noverr MC; Fidel PL
mBio; 2017 Mar; 8(2):. PubMed ID: 28292981
[TBL] [Abstract][Full Text] [Related]
20. Local production of chemokines during experimental vaginal candidiasis.
Saavedra M; Taylor B; Lukacs N; Fidel PL
Infect Immun; 1999 Nov; 67(11):5820-6. PubMed ID: 10531235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
